CRID PHARMA Forms Partnership with US Leader CSM
Saint Gely du Fesc, France
CRID PHARMA announced a partnership with Clinical Supplies Management (CSM) , a supplier of innovative clinical trial services, to biotechnology and pharmaceutical companies. With a combined 34 years of providing clinical supply services, the partnership brings two companies together looking to broaden their expertise and address a growing customer demand. The companies will share resources and assist one another with global distribution allowing clients to expand their clinical trials.
“We will offer competitive technologies from CMC development and On-Demand distribution through manufacturing capacities dedicated to clinical trials,” said Jean-Pascal Conduzorgues, Chief Executive Officer of CRID PHARMA.
The commitment to providing expert clinical trial solutions to reduce time and costs is the driving force behind the partnership, Gerald Finken, Chief Executive Officer of CSM said.
“This is a unique partnership, one that will be transparent to the client,” Finken said,.“This allows us to double our service capabilities and ultimately provide On-Demand packaging and labeling in Europe.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
